Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis to Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07171216
What this trial is testing

The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density

Who this might be right for
Chronic Kidney Disease Mineral and Bone Disorder
Herlev Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT03304730
What this trial is testing

Prognostic Factors in Zygapophyseal Osteoarthritis Infiltration: a Prospective Cohort Study

Who this might be right for
Degenerative Arthropathy of Lumbar Spinal Facet Joint
Hospital Israelita Albert Einstein 147
Early research (Phase 1)Study completedNCT00544804
What this trial is testing

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Who this might be right for
Breast CancerMetastatic Cancer
University of California, San Francisco 41
Testing effectiveness (Phase 2)Study completedNCT01588821
What this trial is testing

Cabozantinib in Advanced Solid Malignancies

Who this might be right for
Lung CancerSolid Tumor (Not Breast or Prostate Cancers)
Massachusetts General Hospital 37
Not applicableEnded earlyNCT02999152
What this trial is testing

Validation of Radio-induced Damage Biomarkers

Who this might be right for
Bone MetastasisMalignant Hemopathy
Centre Hospitalier Universitaire de Saint Etienne 16
Not applicableStudy completedNCT02398526
What this trial is testing

Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases

Who this might be right for
Castration-Resistant Prostatic Cancer
Bayer 363
Not applicableStudy completedNCT02981797
What this trial is testing

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Who this might be right for
Prostate CancerProstate Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 10
Large-scale testing (Phase 3)Study completedNCT01932970
What this trial is testing

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 158
Testing effectiveness (Phase 2)Looking for participantsNCT07477457
What this trial is testing

Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Who this might be right for
OsteosarcomaMetastasis
Memorial Sloan Kettering Cancer Center 45
Not applicableStudy completedNCT02876731
What this trial is testing

Comparison of NaF PET-CT and Diffusion MRI in the Diagnosis of Bone Metastases (IMMETAOS)

Who this might be right for
CancerBone Metastasis
Institut Jean-Godinot 13
Not applicableStudy completedNCT01374672
What this trial is testing

Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaOsteoblastic Osteosarcoma+1 more
Children's Oncology Group 20
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04316117
What this trial is testing

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaMetastatic Breast Carcinoma+1 more
ECOG-ACRIN Cancer Research Group 138
Not applicableStudy completedNCT06153576
What this trial is testing

The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures

Who this might be right for
Vertebral Compression FractureMyelomaBone Metastases+3 more
Centre Hospitalier Universitaire de Nice 1,120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Post-approval studies (Phase 4)Study completedNCT00172016
What this trial is testing

Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates

Who this might be right for
Prostate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT00558272
What this trial is testing

Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease

Who this might be right for
Breast CancerProstate CancerBone Neoplasms
AstraZeneca 139
Not applicableStudy completedNCT03188926
What this trial is testing

Surgical Treatment of Long Bone Metastases

Who this might be right for
Bone MetastasesSurgery
Istituto Ortopedico Rizzoli 120
Next Page